Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Inflammatory demyelinating diseases in children: an update.
Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.
Alterations of calcium homeostasis in cultured rat astrocytes evoked by bioactive sphingolipids.
Factors associated with clinically significant increased walking time in multiple sclerosis: Results of a survival analysis of short-term follow-up data from a clinical database.
From the Cajal alumni Achúcarro and Río-Hortega to the rediscovery of never-resting microglia.
Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease.
Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.
Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases.
Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis.
Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness).
Upper limb functional electrical stimulation devices and their man-machine interfaces.
Functional organization of an Mbp enhancer exposes striking transcriptional regulatory diversity within myelinating glia.
NMR and pattern recognition methods in metabolomics: From data acquisition to biomarker discovery: A review.
[Intrathecal immunoglobulin production in the diagnosis and differential diagnosis of multiple sclerosis.]
Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis.
Distinguishing Optic Neuritis in Neuromyelitis Optica Spectrum Disease From Multiple Sclerosis: A Novel Magnetic Resonance Imaging Scoring System.
The evidence for hypoperfusion as a factor in multiple sclerosis lesion development.
Vital role of specialist MS nurses recognised in proposed guideline.
The top clinical trial opportunities in therapeutic apheresis and neurology.
The MacBlue Binary Transgene (csf1r-gal4VP16/UAS-ECFP) Provides a Novel Marker for Visualisation of Subsets of Monocytes, Macrophages and Dendritic Cells and Responsiveness to CSF1 Administration.
Specialized housing and transportation needs of adults with multiple sclerosis.
Perceived cognitive decline in multiple sclerosis impacts quality of life independently of depression.
Brain-derived neurotrophic factor deficiency restricts proliferation of oligodendrocyte progenitors following cuprizone-induced demyelination.
(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects.
Pages
« first
‹ previous
…
342
343
344
345
346
347
348
349
350
…
next ›
last »